BiotechTube
Home/NewAmsterdam Pharma/Dr. Michael Davidson
DM

Dr. Michael Davidson

Co-founding Chief Executive Officer

NewAmsterdam Pharma

Roles

Co-founding Chief Executive OfficeratNewAmsterdam Pharma
Co-founding Chief Executive OfficeratNewAmsterdam Pharma Company

Therapeutic Areas

Cardiovascular DiseaseDyslipidemiaAlzheimer's Disease

NewAmsterdam Pharma Pipeline

DrugIndicationPhase
Obicetrapib MonotherapyHeterozygous Familial Hypercholesterolemia (HeFH)Phase 3
Obicetrapib + Ezetimibe (FDC)HeFH and/or ASCVDPhase 3
ObicetrapibCardiovascular OutcomesPhase 3

Leadership Team at NewAmsterdam Pharma

PD
Professor Dr. John Kastelein
Co-founder and Chief Scientific Officer
BJ
B.J. Jones
Chief Commercial Officer
View full NewAmsterdam Pharma profile